发明名称 Beta 1,3-N-acetylglucosaminyltransferase, DNA encoding it and its use
摘要 <p>The present invention provides pharmaceutical preparations for anti-inflammation, anti-infection, inhibition of cancer metastasis etc., foods such as dairy products etc., and a method for improving proteins, as well as a method for diagnosis of inflammatory diseases and cancer malignancy. According to the present invention, there can be provided a polypeptide having poly-N-acetyllactosamine sugar chains synthesis-related activity, a process for producing the polypeptide, DNA coding for the polypeptide, a process for producing the DNA, a recombinant vector having the DNA integrated therein, a transformant carrying the recombinant vector, an antibody recognizing the polypeptide, a process for producing poly-N-acetyllactosamine sugar chains by use of the DNA or the polypeptide, diagnosis and treatment of diseases such as inflammations, cancers etc. by use of the DNA, the polypeptide or the antibody, determination and immunostaining of the polypeptide of the present invention by use of the antibody, a method for screening a compound varying the expression of a gene coding for the polypeptide, and a method for screening a substance varying the activity of the polypeptide.</p>
申请公布号 EP0937775(A2) 申请公布日期 1999.08.25
申请号 EP19980120589 申请日期 1998.10.30
申请人 KYOWA HAKKO KOGYO CO., LTD.;THE BURNHAM INSTITUTE 发明人 SASAKI, KATSUTOSHI;MIURA, KAZUMI;NAKAGAWA, SATOSHI;NISHI, TATSUNARI;SEKINE, SUSUMU;FUKUDA, MINORU
分类号 C12N9/10;C12N15/54;(IPC1-7):C12N9/10;C12N5/10;C12N15/70;A01H5/00;A01K67/027;G01N33/50;G01N33/68;C07K16/40;G01N33/574;C12Q1/68;C12N15/10;C12P21/00 主分类号 C12N9/10
代理机构 代理人
主权项
地址